RecruitingNCT06169436
Translational Cancer Observational Protocol
2014 Transizionali - Observational Study on the Occurrence of Relapses and on the Quality of Life in Patients Who Underwent Nephroureterectomy Surgery
Sponsor
IRCCS San Raffaele
Enrollment
1,250 participants
Start Date
Jul 17, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- years or older
- Upper tract urothelial cancer diagnosis
- Indication to cancer removal through nephroureterectomy surgery
- Ability to read and sign the informed consent
Exclusion Criteria3
- Age < 18 years
- Absence of upper tract urothelial cancer
- Inability to read and sign the informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURENephroureterectomy
Removal of cancer mass by urether and kidney complete resection.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06169436
Related Trials
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
NCT0677413152 locations
The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
NCT070774475 locations
A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery
NCT062104901 location
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
NCT059128161 location
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
NCT063542311 location